Influence of HLA-DR phenotype on tumor necrosis factor-alpha production in renal-transplant recipients

Nephron. 1995;71(2):180-3. doi: 10.1159/000188709.

Abstract

In healthy subjects, previous studies have demonstrated a great interindividual variability in the ability for tumor necrosis factor-alpha (TNF-alpha) production. The gene for TNF-alpha is closely linked to and located in the major histocompatibility complex (MHC) and it has been suggested that these interindividual differences may be HLA related. Since TNF-alpha is likely to be an important mediator in renal allograft rejection, we investigated the role of HLA antigens on TNF-alpha production rates by peripheral blood mononuclear cells (PBMC) from renal transplant recipients during stable graft function. HLA-DR2-positive recipients showed significantly lower spontaneous TNF-alpha production than DR2-negative patients (p < 0.001). Upon stimulation with OKT3, HLA-DR2-positive patients also showed significantly lower TNF-alpha production than DR2-negative subjects (p < 0.001). HLA-DR3-positive recipients, however, showed significantly higher spontaneous TNF-alpha production than DR3-negative individuals (p < 0.05). These results suggest that differences in TNF-alpha production, both spontaneous and induced, may be due to the expression of certain DR allotypes.

MeSH terms

  • Cyclosporine / administration & dosage
  • Graft Rejection / genetics
  • Graft Rejection / immunology
  • HLA-DR Antigens / genetics*
  • Histocompatibility Testing
  • Humans
  • Kidney Transplantation*
  • Leukocytes, Mononuclear / immunology
  • Leukocytes, Mononuclear / metabolism
  • Phenotype
  • Tumor Necrosis Factor-alpha / biosynthesis
  • Tumor Necrosis Factor-alpha / immunology*

Substances

  • HLA-DR Antigens
  • Tumor Necrosis Factor-alpha
  • Cyclosporine